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The Effect of the Intervening Variables Age, Sex and Overweight
on the Intravenous Glucose Tolerance Test ,
By J. D. KRUSE-JARRES and J. WERNER
Clinical Chemistry Laboratory of the Surgical Clinic, University of Freiburg and Faculty of Social Sciences>
University of Mannheim '
(Eingegangen am 15. Juni/12. November 1972)
The values for kG of the intravenous glucose tolerance test on 192 metabolically healthy as well as diabetic test persons were subjected
to a three-dimensional variance analysis in order to examine the dependence of the glucose tolerance on age, sex and overweight. A
dependence on overweight and sex could not be detected, whereas a significant fall of the values for ko with age can be observed at the
1% niveau. This dependence, however, is probably not entirely accounted for by age per se, but rather by concomitant variables Connected
with age. In view of the multidimensionality of the glucose tolerance variable, the authors consider it too early at present to establish
appropriate age-dependent "normal ranges".
Die ko-Werte des intravenösen Glucose-Toleranztest von 192 stoffwechselgesunden und diabetischen Probanden wurden zur Prüfung
der Abhängigkeit der Glucosetoleranz von Alter, Geschlecht und Übergewicht einer dreidimensionalen Varianzanalyse unterzogen.
Während die Geschlechtsverteilung an der Grenze zur Signifikanz liegt, konnte eine Abhängigkeit vom Übergewicht nicht festgestellt
werden. Hingegen' zeigt sich auf dem 1%-Niveau ein signifikanter Abfall der kG-Werte mit dem Alter.
Diese Abhängigkeit ist wahrscheinlich jedoch nicht vollständig durch das Alter per se, eher durch die Summe nicht direkt altersbedingter
intervenierender Variabler erklärbar. Aufgrund der Multidimensionalität der Glucosetoleranz erscheint es den Verfassern zur Zeit ver-
früht, entsprechende altersbedingte „Normbereiche" anzugeben.
In a study of the intravenous glucose tolerance test
published earlier, we placed the normal range of the
glucose assimilation coefficient (kG) at 1.0—2.5 (1).
This normal range was «evaluated by taking into con-
sideration a number of factors, but not age, sex and
overweight. The emphasis lay mainly on the dependence
of dose on body weight.
LUNDBAEK (2), BOGORUS (3), KIENHOLZ (4), and very
recently, LAZAROVICI (5), WOSEGIEN (6) and KNICK (7)
were able to find statistically significant age-dependent
differences in the oral glucose tolerance test in the
sense that the tolerance value diminished with age.
With regard to the intravenous glucose tolerance test,
SCHILLING (8) found no age-dependent tolerance
decrease in normals, but a clear decrease in adipose
individuals. Age and body weight therefore appear to
have an effect on the tolerance niveau of glucose.
The effect of these two intervening variables on the
intravenous glucose tolerance test has also been in-
vestigated in the present study. In addition, the variable
of sex has been taken into consideration, since it might
also have an influence on the tolerance value.
Method:
From the clientel of the Institute of Clinical Chemistry of the
„Mannheim Municipal Hospital during the period of 1969 to 1971,
two groups of patients were selected, which may be described as
follows: The test group consisted of 100 males and 92 females, of
whom 143 were non-diabetic persons, with a normal metabolism
as far as could be ascertained, and 49 diabetics. Thus the3 intra-
venous glucose tolerance test using 0.33 g glucose per kg body
weight was carried out on 192 test persons. The continuous in
vivo analysis of blood glucose is described elsewhere (9). ko-values
were determined for the test persons relative to the three variables
under consideration. According to the findings mentioned above,
it is to be expected that, for instance, older and overweight persons
would have a lower tolerance value. For the statistical analysis
of this question, a three-dimensional variance analysis (10) is
available, which uses the variables of age, overweight in percentage
of deviation from the ideal weight1), and sex. For purposes of
variance analysis, the random sample of 192 test persons is thus
divided into 4 - 4 - 2 groups (cf. Tab. 1, 2: data cell frequencies of
the analysis of variance design) and the extent to which the mean
values of these groups are statistically different is investigated.
Tab. 1
Male probands; overweight in percentage of deviation from the ideal
weight: data cell frequencies of the analysis of variance design





































































) Weight with the highest life expectancy (According to Statist.
• Bull. Metrop. Life Insur. Co., 40, 11 (1959)).
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Tab. 2
Female probands, overweight in percentage of deviation from the
ideal weight: data cell frequencies of the analysis of variance design



























































The expansions of the levels of the first two factors were per-
formed approximately in a few steps, since the number of test
persons is small in the statistical sense. The following age groups
were selected :0—25, 26—40,41—55 and 56 years and above. The
variable overweight was registered under the following four
categories: 0% to less than 1%, 1% to 10%, 11% to 20% and
21% and above.
Results
The results of the variance analysis are given in Table 3.
It is evident that the factor age is significant at the 1%
confidence level i. e. that the mean values for kG
prove to be different at the different age levels and that,
as can be seen from the cell means, it decreases with .age.
The differences regarding sex just lie at the significance
limit of 1% niveau (the exact error probability of
p = .018 is greater than .01 and therefore not significant
at the 1% niveau). The interesting fact is that we could
find no differences in the values for kG related to
overweight and that no interactions are of statistical
significance, i. e., for instance, applied to age and
overweight, the values for kG were strictly additive
(linear and not multilinear) and thereby contradict the
results obtained by SCHILLING (8), viz. that a clear
deterioration of tolerance appears with age in adipose
patients and none in normal weight individuals.
As revealed by the description of our random sample
of test persons, our collection of patients contained
individuals with normal metabolism as well as cases of
varying degrees of diabetes. It is safe to assume that the
course of glucose tolerance with respect to the three
factors under investigation would be different in the
case of test persons with metabolic disease from that
in healthy individuals.
We therefore introduced the variable, healthy-diseased,
as a co-variable into the above analysis of variance,
thereby eliminating the effect of the variable, healthy-
diseased, from its three-dimensional AV-design.
After elimination of the effect of the variable, healthy-
diseased, different mean values for kG (oc < 0.1) are
only obtained for the age factor. (The regression of the
Tab. 3
Analysis of variance: three factors age, sex and overweight
This analysis was calculated using the MONOVA-program of the
Rechenzentrum Mannheim
SS = sums of squares, DF = Degrees of freedom,
MS «= Mean square (SS/DF), F — Result of analysis of variance







Age χ % overweight
Age χ sex
% overweight κ sex
















































Analysis of variance: three factors age, sex and overweight. Co-
variable: healthy-diseased
This analysis was calculated using the MONOVA-program of the
Rechenzentrum Mannheim
SS = sums of squares, DF = Degrees of freedom,
MS « Mean square (SS/DF), F » Result of analysis of variance
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co-variable, healthy-diseased, on the values of kG is
trivially significant, since the test persons are not in the
last place classified on basis of this value into meta-
bolically healthy and metabolically diseased.)
No less important than the ascertainment that age
differences are valid for glucose tolerance is the in-
vestigation of the corresponding trend of values for
intravenous glucose tolerance test over the age groups.
The determination of the function of this trend is
important, for example, for the derivation of age-
dependent correction formulas. Since nothing is a
priori known about the nature of the functional relation
between the variables, age and glucose tolerance, it is
suitable to start from polynomial equations and then
examine which function best fits to the data. The
fitting of the polynomial curve was carried out seperately
for metabolically diseased and metabolically healthy
test persons: The metabolically diseased group shows
no significant trend at all, whereas for the metabolically
healthy group the polynomials are satisfactorily sig-
nificant up to third degree2).
2) The polynomial curve fitting was carried out using the BMD
05 R program of the Rechenzentrum Mannheim.
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Discussion
A determination of polynomials reliable in the statistical
sense could not be carried out because of the low num-
ber of test persons especially in the metabolically 'diseased
group (N = 50). The results of the polynomial fitting
are only of an exploratory character and will be re-
evaluated by the authors when larger numbers of test
persons are available: In the metabolically healthy
group, the mathematical representation of the relation-
ship between age and values for kG cannot be adequately
characterized by a simple linear regression, for it
contains square and cubic components in addition. In
the metabolically diseased group, however, not even the
linear regression is stastistically significant (Fig. 1:
the linear function is parallel to the x-axis). This result
appears to be plausible and would mean that the values
for kG do not change with age in the case of meta-
bolically diseased patients.
The interpretation of the results of the group of dia-
betics is obvious; that of the metabolically healthy test
persons, on the other hand, is not as unequivocal as it
might appear at the first sight: The deterioration of
tolerance due to age is frequently accounted for by
making correctiohs on the basis of regressively age-
dependent "normal ranges". In view of the evaluations
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Age-dependence of the mean assimilation coefficients in the intra-
venous glucose tolerance test in the case of metabolically healthy per-
sons (left) and diabetic patients (right)
of our data, a normal range of 1.68 ± 0.53 up to the
age of 25 years and one of 1.39 ± 0.35 at ages of 56
years and above would have to be assumed. On the
other hand, DIETERLE (11) found that the glucose
tolerance in the various decades of life, after elimination
of all risk factors (such as diseases of the liver, diseases
of the vessels, essential. hypertension, chronic in-
flammations of the pancreas, repeated stress situations
etc.), is identical up to the 60th year of age.
Attention has repeatedly been drawn to the differences
between the chronological or calendar age on the one
hand and the biological or functional age on the other
hand (12). The former is orientated on the continuous
physical time; the latter is indeed basically related to
the former^ but can, however, deviate from it con-
siderably in individual cases. These deviations are
yielded by the difference between the sums of the age-
independent and the age-specific risk factors. It is,
however, not yet possible to estimate the magnitude of
the effects and the affiliation' of the individual variables.
In particular, it is not conclusively known whether the
dependence of glucose tolerance on age can be entirely
explained by means of the risk factors mentioned or
whether there are age-specific variations in the metab-
olism of glucose in addition to those caused by the
risk factors.
In view of the multifactoral causality of the glucose
tolerance and the related aetiologies! obscurity of the
effects of "age-dependent variables", it appears to us to
be neither necessary nor helpful for the present prag-
matical handling of the intravenous glucose tolerance
test as an indicator of diabetes to cite a "normal range
for age". This is often done and leads to a judgement
on basis of "normal ranges" recruited from the sta-
tistical mean values of effects that are often not valid
for the individual case. Furthermore, we do not consider
it justified to view the incorporation of such staggered
results into the clinical diagnosis as being "revealing
and, in the younger and middle years of age, meaningful
indeed in general" (12). As long as the clarification of
all age-specific risk factors is incomplete, this is 'equi-
valent to trying to improve the quality of a test without
checking for validity.
References
1. KRUSE-JARRES, J. D., HILPERT, C, GROHMANN, K. & KLING-
M LLER, V. (1971), Deut. Med. Wochenschr. 96, 1424—1430. —
2. LUNDBAEK, K. (1964), Z. Med. Wiss. 6, 194—197. — 3. Bo-
GORUS, M. S. & GILBERT, J. A. (1966), Can. Med. Ass. J. 94, 660.
4. KIENHOLZ, M. (1967), Med. Welt 18, 2760. — 5. LAZAROVICI,
A. M., LABRAM, C., DALLE, J. & LESTRADET, H. (1969), Presse
Med. 77, 2143—2144. — 6. WOSEGIEN, F. (1971), Deut. Med.
Wochenschr. 96, 1697. — 7. KNICK, B. (1972), Med. Klin.
67, 34—35. — 8. SCHILLING, W. H., OBERDISSE, K., H TER, K.
A. & BLANK, H. (1965), Diabetologia /, 187—194. — 9. KRUSE-
JARRES, J. D., REITER, J. & KLINGM LLER, V. (1969), Klin.
Wochenschr. 47, 462—469. — 10. WINER, B. J. (1962), Statisti-
cal Principles in Experimental Design, Me Graw Hill, New York.
— 11. DIETERLE, P. (1971), Internist 12,463—466. —12: B CHER,
R. (1971), Fortschr. Med. 89, 979—982. — 13. FRANCKSON^ J. R.
M., OOMS, Η. Α., BELLENS, R., CONRAD, V. & BASTENIE, P. A.
(1972), Metab. Clin. Exp. //, 482—500.
Priv. Ροζ. Dr. med. J. D. Kruse-Jarres
Klinisch-Chemisches Labor
Chirurgische Universit tsklinik
D 78 Freiburg i. Br.
Hugstetter Stra e 55
Z. Klin. Chem. Klin. Biochemt / 11. Jahrg. 1973 / Heft 3
